VANCOUVER, British Columbia, April 28, 2021 (Globe Newswire) – Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “MEDI”) is pleased to announce that it has recently engaged Meadowbank Strategic Partners Inc. (“Meadowbank”), a corporate consultancy based in Calgary, Alberta, to provide investor relations, capital markets and corporate development advisory services (the “Services”) for an initial term of six months (the “Initial Term”), subject to the terms of the consulting agreement (the “Agreement”) entered into between the MEDI and Meadowbank. Certain functions and aspects of the Services provided by Meadowbank are anticipated to include “investor relations activities” under the policies of the CSE and applicable securities laws. As such, Meadowbank has agreed to comply with all applicable securities laws and the policies of the CSE in providing the Services.
Pursuant to the terms of the Agreement, Meadowbank will be paid a minimum cash fee of $3,500 plus GST, per month, for its Services during the Initial Term. Meadowbank will not receive any securities in the capital of the Company as compensation for its Services. Neither Meadowbank nor its principal currently own any securities of MEDI, however, Meadowbank, its principal and its affiliates may acquire or be awarded an interest in the securities of the Company at a future time. The Services are being provided at an arm’s length as MEDI and Meadowbank are unrelated and unaffiliated entities. For more information about Meadowbank, please visit www.mdwbnk.com.
ABOUT MYCONIC
Myconic Capital Corp. is an investment issuer with a diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining and health & wellness sectors.
On behalf of:
MYCONIC CAPITAL CORP.
“Robert Meister”
Robert Meister
CEO and Director
For further information, please contact:
Robert Meister
+1 604-351-6647
rob@auraliteinvestments.com
The Canadian Securities Exchange (the “CSE”) has not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Notice Regarding Forward Looking Information:
This news release contains forward-looking statements including statements regarding any of the Myconic holdings or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business, and future prospects of the Company.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.